Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The peptidoglycan precursor containing the sequence Lys-D-Ala-D-Ala is a peptide motif found in the biosynthetic pathway of bacterial cell wall peptidoglycan. This tripeptide is a critical component of the stem peptide attached to N-acetylmuramic acid in Gram-positive bacteria, where L-lysine replaces meso-diaminopimelic acid (used by many Gram-negative bacteria) as the third amino acid in the chain. The terminal D-Ala-D-Ala dipeptide is essential for cross-linking reactions catalyzed by penicillin-binding proteins (PBPs), which are targeted by β-lactam antibiotics and glycopeptides like vancomycin.
β-lactams mimic the structure of the terminal D-Ala–D-Ala dipeptide, irreversibly acylating PBPs and blocking transpeptidation. Glycopeptides like vancomycin bind non-covalently to this motif, preventing enzyme access required for cross-linking peptidoglycan strands.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan Precursor (Lys-D-Ala-D-Ala) (None).